195 related articles for article (PubMed ID: 22659236)
21. In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan.
Krauland AH; Leitner VM; Grabovac V; Bernkop-Schnürch A
J Pharm Sci; 2006 Nov; 95(11):2463-72. PubMed ID: 16886206
[TBL] [Abstract][Full Text] [Related]
22. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
Biomacromolecules; 2009 Feb; 10(2):243-9. PubMed ID: 19117404
[TBL] [Abstract][Full Text] [Related]
23. Mucin-controlled drug release from mucoadhesive phenylboronic acid-rich nanoparticles.
Li C; Liu Z; Yan X; Lu W; Liu Y
Int J Pharm; 2015 Feb; 479(1):261-4. PubMed ID: 25528296
[TBL] [Abstract][Full Text] [Related]
24. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
25. On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs.
Bae HD; Lee K
J Control Release; 2013 Sep; 170(3):358-64. PubMed ID: 23791976
[TBL] [Abstract][Full Text] [Related]
26. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
Sajeesh S; Sharma CP
Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
[TBL] [Abstract][Full Text] [Related]
27. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
28. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
[TBL] [Abstract][Full Text] [Related]
29. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
du Plessis LH; Kotzé AF; Junginger HE
Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
[TBL] [Abstract][Full Text] [Related]
30. Development of mucoadhesive drug delivery system using phenylboronic acid functionalized poly(D,L-lactide)-b-dextran nanoparticles.
Liu S; Jones L; Gu FX
Macromol Biosci; 2012 Dec; 12(12):1622-6. PubMed ID: 23165800
[TBL] [Abstract][Full Text] [Related]
31. Nasal delivery of insulin using bioadhesive chitosan gels.
Varshosaz J; Sadrai H; Heidari A
Drug Deliv; 2006; 13(1):31-8. PubMed ID: 16401591
[TBL] [Abstract][Full Text] [Related]
32. Glucose- and temperature-sensitive nanoparticles for insulin delivery.
Wu JZ; Williams GR; Li HY; Wang D; Wu H; Li SD; Zhu LM
Int J Nanomedicine; 2017; 12():4037-4057. PubMed ID: 28603417
[TBL] [Abstract][Full Text] [Related]
33. Microencapsulated chitosan nanoparticles for lung protein delivery.
Grenha A; Seijo B; Remuñán-López C
Eur J Pharm Sci; 2005; 25(4-5):427-37. PubMed ID: 15893461
[TBL] [Abstract][Full Text] [Related]
34. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
Su FY; Lin KJ; Sonaje K; Wey SP; Yen TC; Ho YC; Panda N; Chuang EY; Maiti B; Sung HW
Biomaterials; 2012 Mar; 33(9):2801-11. PubMed ID: 22243802
[TBL] [Abstract][Full Text] [Related]
35. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
36. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
[TBL] [Abstract][Full Text] [Related]
37. Statistical optimization of insulin-loaded Pluronic F-127 gels for buccal delivery of basal insulin.
Das N; Madan P; Lin S
Pharm Dev Technol; 2012; 17(3):363-74. PubMed ID: 21214425
[TBL] [Abstract][Full Text] [Related]
38. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
39. New strategies to improve the intranasal absorption of insulin.
Duan X; Mao S
Drug Discov Today; 2010 Jun; 15(11-12):416-27. PubMed ID: 20359545
[TBL] [Abstract][Full Text] [Related]
40. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
Krauland AH; Guggi D; Bernkop-Schnürch A
Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
